Author: Hellman, Urban; Karlsson, Mats G.; Engström-Laurent, Anna; Cajander, Sara; Dorofte, Luiza; Ahlm, Clas; Laurent, Claude; Blomberg, Anders
Title: Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? Cord-id: 44pz8li3 Document date: 2020_11_6
ID: 44pz8li3
Snippet: Severe coronavirus disease 2019 (Covid-19) is characterized by inflammation of the lungs with increasing respiratory impairment. In fatal Covid-19, lungs at autopsy have been filled with a clear liquid jelly. However, the nature of this finding has not yet been determined. The aim of the study was to demonstrate whether the lungs of fatal Covid-19 contain hyaluronan, as it is associated with inflammation and acute respiratory distress syndrome (ARDS) and may have the appearance of liquid jelly.
Document: Severe coronavirus disease 2019 (Covid-19) is characterized by inflammation of the lungs with increasing respiratory impairment. In fatal Covid-19, lungs at autopsy have been filled with a clear liquid jelly. However, the nature of this finding has not yet been determined. The aim of the study was to demonstrate whether the lungs of fatal Covid-19 contain hyaluronan, as it is associated with inflammation and acute respiratory distress syndrome (ARDS) and may have the appearance of liquid jelly. Lung tissue obtained at autopsy from three deceased Covid-19 patients was processed for hyaluronan histochemistry using a direct staining method and compared with staining in normal lung tissue. Stainings confirmed that hyaluronan is obstructing alveoli with presence in exudate and plugs, as well as in thickened perialveolar interstitium. In contrast, normal lungs only showed hyaluronan in intact alveolar walls and perivascular tissue. This is the first study to confirm prominent hyaluronan exudates in the alveolar spaces of Covid-19 lungs, supporting the notion that the macromolecule is involved in ARDS caused by SARS-CoV-2. The present finding may open up new treatment options in severe Covid-19, aiming at reducing the presence and production of hyaluronan in the lungs.
Search related documents:
Co phrase search for related documents- accumulation production and acute inflammation: 1
- accumulation production and acute lung injury: 1, 2
- accumulation production and acute respiratory distress syndrome: 1
- accumulation production and acute respiratory distress syndrome ards: 1
- active inflammation and acute ards respiratory distress syndrome: 1, 2
- active inflammation and acute inflammation: 1, 2, 3
- active inflammation and acute inflammation ards respiratory distress syndrome: 1, 2
- active inflammation and acute lung injury: 1, 2, 3, 4
- active inflammation and acute respiratory distress syndrome: 1, 2, 3
- active inflammation and acute respiratory distress syndrome ards: 1, 2
- active inflammation and low molecular: 1, 2
- acute ards respiratory distress syndrome and additional information: 1, 2, 3
- acute ards respiratory distress syndrome and adjuvant treatment: 1, 2, 3, 4
- acute ards respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute ards respiratory distress syndrome and lung alveolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute inflammation and additional information: 1
- acute inflammation and adjuvant treatment: 1
- acute inflammation and low molecular: 1, 2, 3
- acute inflammation and lung alveolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
Co phrase search for related documents, hyperlinks ordered by date